← NovaBridge Biosciences
| Annual Trend | FY 2011 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income From Continuing Operations | — | — | — | — | — | — | — | — | ($49.7m) | ($88.3m) | |
| Net Income (Loss) Attributable to Parent | — | — | ($402.8m) | ($208.6m) | $72.2m | ($365.9m) | ($363.5m) | ($206.4m) | ($22.2m) | ($46.3m) | |
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | ($402.8m) | ($213.3m) | $72.2m | ($365.9m) | ($363.5m) | ($206.4m) | ($22.2m) | ($46.3m) | |
| Less: net gain (loss) from discontinued operations | — | — | — | — | — | — | ($229.8m) | ($125.5m) | $27.5m | $0 | |
| Net loss from continuing operations | — | — | — | — | — | — | ($141.2m) | ($82.2m) | ($49.7m) | ($88.3m) | |
| Net cash used in discontinued operations | — | — | — | — | — | — | ($40.6m) | ($73.8m) | ($54.0m) | $0 | |
| Cash and cash equivalents in current assets of discontinued operations | — | — | — | — | — | — | $8.9m | $10.8m | — | — | |
| Restricted cash in non-current assets of discontinued operations | — | — | — | — | — | — | $118.6m | $8.3m | — | — | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | — | — | ($88.3m) | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | — | — | ($438.6m) | ($210.4m) | $23.8m | ($325.0m) | ($285.5m) | ($197.0m) | ($49.7m) | ($46.3m) | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | — | — | ($88.3m) | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | — | $27.5m | $0 | |
| Net Income (Loss) Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | — | — | ($42.1m) | |
| Depreciation, Depletion and Amortization | — | — | $6.7m | $9.8m | $12.7m | $13.8m | $3.7m | $3.4m | $300k | $856k | |
| Depreciation | — | — | $6.7m | $1.4m | $2.0m | $2.2m | $3.7m | $3.4m | $261k | $68k | |
| Amortization of Intangible Assets | — | — | — | — | $238k | $122k | $113k | $110k | — | — | |
| Depreciation of property, equipment and software | — | $1.6m | $6.7m | $9.8m | $12.7m | $13.8m | $25.3m | $23.9m | $261k | $68k | |
| Amortization of right-of use assets | — | — | — | — | — | — | $1.2m | $586k | $717k | $788k | |
| Amortization Cash Flow | — | — | — | — | — | $122k | $113k | $110k | — | — | |
| Amortization Of Intangibles | — | — | — | — | — | $122k | $113k | $110k | — | — | |
| Depreciation Amortization Depletion | — | — | — | — | — | — | — | — | $978k | $856k | |
| Share-based Payment Arrangement, Noncash Expense | — | — | $3.5m | $52.7m | $75.6m | $95.5m | $51.8m | $27.2m | ($1.9m) | $6.0m | |
| Share-based Payment Arrangement, Expense | — | — | — | — | $80.6m | $97.6m | $53.8m | $27.9m | $1.5m | — | |
| Equity Method Investment, Other than Temporary Impairment | — | — | — | — | — | — | $0 | $0 | — | — | |
| Goodwill, Impairment Loss | — | — | — | — | — | — | $0 | $22.9m | $0 | $0 | |
| Impairment of Intangible Assets, Finite-lived | — | — | $0 | $0 | $0 | $0 | $0 | $0 | — | — | |
| Share-based compensation | $2.5m | $7.0m | $3.5m | $366.9m | $493.5m | $608.6m | $357.1m | $193.0m | ($1.9m) | $6.0m | |
| Impairment of goodwill | — | — | — | — | — | $0 | $0 | $162.6m | $0 | $0 | |
| Asset Impairment Charge | — | — | — | — | — | — | $0 | — | $1.2m | $0 | |
| Equity Method Investment, Realized Gain (Loss) on Disposal | — | — | — | — | $62.5m | — | — | — | — | — | |
| Gain (Loss) on Disposition of Business | — | — | — | — | $62.5m | — | — | — | — | — | |
| Gain (Loss) on Disposition of Property Plant Equipment | — | $79k | — | — | ($1k) | ($45k) | ($17k) | ($69k) | $11k | ($16k) | |
| Income (Loss) from Equity Method Investments | — | — | — | — | ($16.6m) | ($57.7m) | ($63.4m) | ($11.3m) | ($1.0m) | — | |
| Income Tax Expense (Benefit) | — | — | $1.7m | — | $1.9m | ($495k) | $101k | — | $0 | $0 | |
| Other Nonoperating Income (Expense) | — | — | ($16.8m) | ($2.9m) | $63.3m | $13.1m | ($18.4m) | ($5.4m) | ($4.7m) | ($1.7m) | |
| Operating lease liability, net | — | — | — | — | — | — | ($1.2m) | ($575k) | ($588k) | ($816k) | |
| Right-of-use assets obtained in exchange for operating lease obligations | — | — | — | $8.6m | $7.5m | $118.4m | $9.9m | $11.1m | $282k | — | |
| Earnings (Loss)es From Equity Investments | — | — | — | — | — | — | — | — | $1.0m | $0 | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| Increase (Decrease) in Accounts Receivable | — | — | — | — | $20.0m | ($15.3m) | ($4.8m) | — | — | — | |
| Increase (Decrease) in Inventories | — | — | — | — | — | $4.3m | ($3.9m) | — | — | — | |
| Proceeds from Stock Options Exercised | — | — | — | — | $1.4m | $8.1m | $6.5m | $393k | — | $200k | |
| Deconsolidation, Gain (Loss), Amount | — | — | — | — | — | — | — | ($1.1m) | — | — | |
| Equity Securities, FV-NI, Unrealized Gain (Loss) | — | — | — | — | — | — | — | — | — | ($5.2m) | |
| Foreign Currency Transaction Gain (Loss), before Tax | — | — | $742k | $233k | ($3.4m) | $4.0m | ($25.4m) | ($8.6m) | ($5.6m) | ($4k) | |
| General and Administrative Expense | — | — | $66.4m | $94.0m | $61.7m | $141.2m | $118.3m | $63.8m | $29.7m | $31.4m | |
| Goodwill | — | — | $162.6m | $23.4m | $24.9m | $25.5m | $23.6m | — | — | — | |
| Investment Income, Interest | — | — | $4.6m | $4.4m | $3.7m | $3.3m | $3.9m | $7.3m | $7.5m | $7.6m | |
| Operating Expenses | — | — | — | — | — | — | — | — | $51.4m | $94.3m | |
| Net loss | ($3.1m) | ($298.2m) | ($402.8m) | ($1.5b) | — | ($2.3b) | ($2.5b) | ($1.5b) | ($22.2m) | ($88.3m) | |
| Change in fair value and extinguishment of put right liabilities | — | — | — | — | — | — | ($5.1m) | $1.1m | ($13.9m) | — | |
| Equity in loss of affiliates | — | — | — | $0 | $108.6m | $367.9m | $437.5m | $80.0m | $1.0m | — | |
| Change in fair value of short-term and other investments | — | — | — | — | — | — | ($1.9m) | ($221k) | — | — | |
| Prepayments and other receivables | — | $8.8m | ($76.3m) | ($48.8m) | ($58.7m) | ($5.2m) | $109.2m | $35.9m | ($1.9m) | ($703k) | |
| Accruals and other payables | — | $408k | $55.6m | $188.4m | $173.7m | $152.1m | $109.9m | ($342.7m) | ($213k) | $18.1m | |
| Other non-current liabilities | — | — | — | — | $7.5m | $6.0m | $2.0m | ($6.2m) | ($106k) | $512k | |
| Accounts receivable | ($170k) | — | — | — | ($130.5m) | $97.4m | $33.1m | — | — | — | |
| Contract assets | — | — | ($11.0m) | $11.0m | ($227.4m) | ($26.4m) | $253.8m | — | — | — | |
| Proceeds from disposal of short-term and other investments | — | — | — | — | $2.5b | $9.5b | $7.9b | $1.0b | $109.8m | $154.9m | |
| Payments of deferred offering costs | — | — | — | ($827k) | ($27.6m) | $0 | — | — | — | $4.2m | |
| Payment for stock repurchases | — | — | — | — | ($34.9m) | $0 | ($21.2m) | ($61.3m) | ($335k) | — | |
| Proceeds from exercise of stock options | — | — | — | — | $9.3m | $51.3m | $44.6m | $2.8m | — | $200k | |
| Unrealized gain/(loss) on available-for-sale debt securities | — | — | — | — | — | — | — | — | $8.2m | $11.6m | |
| Inventories | $173k | — | — | — | — | — | — | — | — | — | |
| Accounts payable | $153k | — | — | — | — | — | — | — | — | — | |
| Beginning Cash Position | — | — | — | — | — | — | — | — | $310.7m | $68.3m | |
| Cash Flow From Continuing Financing Activities | — | — | — | — | — | — | — | — | ($335k) | $57.7m | |
| Cash Flow From Continuing Investing Activities | — | — | — | — | — | — | — | — | ($136.0m) | $105.0m | |
| Cash Flow From Discontinued Operation | — | — | — | — | — | — | — | — | ($54.0m) | $0 | |
| Change In Inventory | — | — | — | — | — | ($4.3m) | $3.9m | $0 | — | — | |
| Change In Other Current Liabilities | — | — | — | — | — | — | — | — | ($694k) | ($304k) | |
| Change In Other Working Capital | — | — | — | — | — | $34.0m | $7.6m | $2.5m | — | — | |
| Change In Payables And Accrued Expense | — | — | — | — | — | — | — | — | ($213k) | $18.1m | |
| Change In Prepaid Assets | — | — | — | — | — | — | — | — | ($1.9m) | ($703k) | |
| Change In Receivables | — | — | — | — | — | $11.1m | — | $0 | $0 | — | |
| Change In Working Capital | — | — | — | — | — | — | — | — | ($2.8m) | $17.1m | |
| Changes In Account Receivables | — | — | — | — | — | $15.3m | — | $0 | $0 | — | |
| Changes In Cash | — | — | — | — | — | — | — | — | ($243.0m) | $142.1m | |
| End Cash Position | — | — | — | — | — | — | — | — | $68.3m | $210.6m | |
| Financing Cash Flow | — | — | — | — | — | — | — | — | ($335k) | $57.7m | |
| Free Cash Flow | — | — | — | — | — | — | — | — | ($52.7m) | ($20.6m) | |
| Gain Loss On Investment Securities | — | — | — | — | — | — | — | — | ($13.9m) | ($3.4m) | |
| Gain Loss On Sale Of Business | — | — | — | — | — | $0 | $0 | $1.1m | — | — | |
| Gain Loss On Sale Of PPE | — | — | — | — | — | — | — | — | ($11k) | $16k | |
| Investing Cash Flow | — | — | — | — | — | — | — | — | ($136.0m) | $105.0m | |
| Issuance Of Capital Stock | — | — | — | — | — | — | $0 | — | $0 | $61.7m | |
| Net Business Purchase And Sale | — | — | — | — | — | ($941k) | $0 | ($821k) | — | — | |
| Net PPE Purchase And Sale | — | — | — | — | — | — | — | — | $14k | $40k | |
| Operating Gains Losses | — | — | — | — | — | — | — | — | ($12.8m) | ($3.4m) | |
| Other Non Cash Items | — | — | — | — | — | — | — | — | $12.4m | $42.1m | |
| Proceeds From Stock Option Exercised | — | — | — | — | — | — | — | — | $0 | $200k | |
| Purchase Of Business | — | — | — | — | — | ($941k) | $0 | ($846k) | — | — | |
| Purchase Of PPE | — | — | — | — | — | — | — | — | ($48k) | ($7k) | |
| Repurchase Of Capital Stock | — | — | — | — | — | — | — | — | ($335k) | $0 | |
| Sale Of Business | — | — | — | — | — | $0 | $0 | $25k | — | — | |
| Sale Of PPE | — | — | — | — | — | — | — | — | $62k | $47k | |
| Stock Based Compensation | — | — | — | — | — | — | — | — | ($1.9m) | $6.0m | |
| Unrealized Gain Loss On Investment Securities | — | — | — | — | — | — | — | — | $0 | $5.2m | |
| Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax | — | — | — | — | — | — | — | — | $34.4m | — | |
| Net Cash Provided by (Used in) Operating Activities | $2.6m | ($252.2m) | ($280.7m) | ($124.7m) | $66.4m | ($152.7m) | ($159.9m) | ($183.8m) | $805k | $1.0m | |
| Cash flows from investing activities: | |||||||||||
| Payments to Acquire Property, Plant, and Equipment | ($701k) | $2.3m | $14.4m | $1.8m | $1.2m | $4.7m | $6.6m | $1.6m | $48k | $7k | |
| Payments to Acquire Investments | — | — | — | — | — | — | $1.1b | $124.7m | — | — | |
| Purchase of short-term and other investments | — | — | — | ($134.0m) | ($2.5b) | ($10.2b) | ($7.4b) | ($885.6m) | ($194.7m) | ($50.0m) | |
| Net Investment Purchase And Sale | — | — | — | — | — | — | — | — | ($136.0m) | $104.9m | |
| Purchase Of Investment | — | — | — | — | — | — | — | — | ($245.9m) | ($50.0m) | |
| Sale Of Investment | — | — | — | — | — | — | — | — | $109.8m | $154.9m | |
| Net cash generated from (used in) investing activities from continuing operations | — | — | — | — | — | — | ($5.2m) | ($15.2m) | ($136.0m) | $105.0m | |
| Net cash (used in) generated from investing activities | — | ($157.7m) | $9.5m | $212.5m | ($201.9m) | ($727.2m) | $458.4m | $102.5m | ($22.3m) | $0 | |
| Net Cash Provided by (Used in) Investing Activities | ($3.6m) | — | $9.5m | $30.5m | ($30.9m) | ($114.1m) | $66.5m | $14.4m | — | — | |
| Cash flows from financing activities: | |||||||||||
| Issuance Of Debt | — | — | — | — | — | $0 | $2.7m | $16.8m | — | — | |
| Net Issuance Payments Of Debt | — | — | — | — | — | $0 | $2.7m | $9.9m | — | — | |
| Net Short Term Debt Issuance | — | — | — | — | — | $0 | $2.7m | $9.9m | — | — | |
| Short Term Debt Issuance | — | — | — | — | — | $0 | $2.7m | $16.8m | — | — | |
| Repayment Of Debt | — | — | — | — | — | $0 | $0 | ($6.9m) | — | — | |
| Short Term Debt Payments | — | — | — | — | — | $0 | $0 | ($6.9m) | — | — | |
| Common Stock Issuance | — | — | — | — | — | — | $0 | — | $0 | $61.7m | |
| Net Common Stock Issuance | — | — | — | — | — | — | — | — | ($335k) | $61.7m | |
| Common Stock Payments | — | — | — | — | — | — | — | — | ($335k) | $0 | |
| Net Other Financing Charges | — | — | — | — | — | ($21.7m) | — | — | — | ($4.2m) | |
| Net cash generated from (used in) financing activities from continuing operations | — | — | — | — | — | — | $3.9m | ($8.2m) | ($335k) | $57.7m | |
| Net cash (used in) generated from financing activities | — | $758.6m | $1.5b | $152.7m | $3.4b | $593.9m | $42.4m | $7.6m | ($4.2m) | $0 | |
| Net Cash Provided by (Used in) Financing Activities | $5.8m | — | $1.5b | $21.9m | $527.3m | $93.2m | $6.1m | $1.1m | — | — | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | $59.8m | $2.2m | ($16.3m) | ($20.2m) | — | — | — | — | |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | — | — | — | $15.2m | ($106.6m) | ($128.8m) | $389.2m | $84.5m | $573k | $276k | |
| Effect Of Exchange Rate Changes | — | — | — | — | — | — | — | — | $573k | $276k | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | $1.3b | ($70.0m) | $546.4m | ($193.8m) | ($30.9m) | ($156.4m) | ($242.4m) | $142.4m | |
| Net increase (decrease) in cash and cash equivalents | — | $348.6m | $1.3b | ($487.6m) | $3.6b | ($1.2b) | ($212.9m) | ($1.1b) | ($242.4m) | $142.4m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | $241.5m | $171.4m | $729.3m | $552.9m | $480.0m | $309.9m | $68.3m | $210.6m | |
| Cash and cash equivalents, beginning of year | — | $412.7m | $1.7b | $1.2b | $4.8b | $3.5b | $3.3b | $2.2b | $68.3m | $210.6m | |
| Cash and cash equivalents | $2.2m | — | — | — | — | — | $342.9m | $291.5m | $68.3m | $210.6m | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Change In Cash Supplemental As Reported | — | — | — | — | — | — | — | — | ($242.4m) | $142.4m | |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | $1.7m | $4.9m | $430k | $147k | $0 | $0 | $99k | $0 | — | |
| Income Taxes Paid, Net | $250k | — | — | — | — | $9.1m | $697k | $0 | $0 | $0 |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.